Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Table of Contents

1 Supply Summary
1.1 Influenza Vaccine Introduction
1.2 World Influenza Vaccine Supply & Forecast
1.2.1 World Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Influenza Vaccine Production (2018-2029)
1.2.3 World Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Influenza Vaccine Production (2018-2029)
1.3.5 Europe Influenza Vaccine Production (2018-2029)
1.3.6 China Influenza Vaccine Production (2018-2029)
1.3.7 Japan Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Influenza Vaccine Major Market Trends
2 Demand Summary
2.1 World Influenza Vaccine Demand (2018-2029)
2.2 World Influenza Vaccine Consumption by Region
2.2.1 World Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Influenza Vaccine Consumption (2018-2029)
2.4 China Influenza Vaccine Consumption (2018-2029)
2.5 Europe Influenza Vaccine Consumption (2018-2029)
2.6 Japan Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Influenza Vaccine Consumption (2018-2029)
2.9 India Influenza Vaccine Consumption (2018-2029)
3 World Influenza Vaccine Manufacturers Competitive Analysis
3.1 World Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Influenza Vaccine in 2022
3.6 Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Influenza Vaccine Market: Region Footprint
3.6.2 Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Influenza Vaccine Production Comparison
4.2.1 United States VS China: Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Influenza Vaccine Production (2018-2023)
4.5 China Based Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Influenza Vaccine Production (2018-2023)
5 Market Analysis by Type
5.1 World Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Trivalent Influenza Vaccine
5.2.2 Quadrivalent Influenza Vaccine
5.3 Market Segment by Type
5.3.1 World Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Influenza Vaccine Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 6 Months to 3 Years
6.2.2 > 3 Years
6.3 Market Segment by Application
6.3.1 World Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Influenza Vaccine Average Price by Application (2018-2029)
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Influenza Vaccine Product and Services
7.1.4 Sanofi Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Influenza Vaccine Product and Services
7.2.4 CSL Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Influenza Vaccine Product and Services
7.3.4 GSK Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Influenza Vaccine Product and Services
7.4.4 Viatris Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Influenza Vaccine Product and Services
7.5.4 AstraZeneca Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Influenza Vaccine Product and Services
7.6.4 Hualan Bio Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Influenza Vaccine Product and Services
7.7.4 Changchun Institute of Biological Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Influenza Vaccine Product and Services
7.8.4 Sinovac Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 BCHT
7.9.1 BCHT Details
7.9.2 BCHT Major Business
7.9.3 BCHT Influenza Vaccine Product and Services
7.9.4 BCHT Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BCHT Recent Developments/Updates
7.9.6 BCHT Competitive Strengths & Weaknesses
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Details
7.10.2 Jiangsu GDK Major Business
7.10.3 Jiangsu GDK Influenza Vaccine Product and Services
7.10.4 Jiangsu GDK Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu GDK Recent Developments/Updates
7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
7.11 KM Biologics
7.11.1 KM Biologics Details
7.11.2 KM Biologics Major Business
7.11.3 KM Biologics Influenza Vaccine Product and Services
7.11.4 KM Biologics Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 KM Biologics Recent Developments/Updates
7.11.6 KM Biologics Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Influenza Vaccine Industry Chain
8.2 Influenza Vaccine Upstream Analysis
8.2.1 Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Influenza Vaccine Production Mode
8.6 Influenza Vaccine Procurement Model
8.7 Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Influenza Vaccine Sales Model
8.7.2 Influenza Vaccine Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List of Tables
Table 1. World Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Influenza Vaccine Production by Region (2018-2023) & (M Units)
Table 7. World Influenza Vaccine Production by Region (2024-2029) & (M Units)
Table 8. World Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Influenza Vaccine Major Market Trends
Table 13. World Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Units)
Table 14. World Influenza Vaccine Consumption by Region (2018-2023) & (M Units)
Table 15. World Influenza Vaccine Consumption Forecast by Region (2024-2029) & (M Units)
Table 16. World Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Influenza Vaccine Producers in 2022
Table 18. World Influenza Vaccine Production by Manufacturer (2018-2023) & (M Units)
Table 19. Production Market Share of Key Influenza Vaccine Producers in 2022
Table 20. World Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Influenza Vaccine Company Evaluation Quadrant
Table 22. World Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Influenza Vaccine Production Site of Key Manufacturer
Table 24. Influenza Vaccine Market: Company Product Type Footprint
Table 25. Influenza Vaccine Market: Company Product Application Footprint
Table 26. Influenza Vaccine Competitive Factors
Table 27. Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Units)
Table 31. United States VS China Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Units)
Table 32. United States Based Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Influenza Vaccine Production (2018-2023) & (M Units)
Table 36. United States Based Manufacturers Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Influenza Vaccine Production (2018-2023) & (M Units)
Table 41. China Based Manufacturers Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Influenza Vaccine Production (2018-2023) & (M Units)
Table 46. Rest of World Based Manufacturers Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Influenza Vaccine Production by Type (2018-2023) & (M Units)
Table 49. World Influenza Vaccine Production by Type (2024-2029) & (M Units)
Table 50. World Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Influenza Vaccine Production by Application (2018-2023) & (M Units)
Table 56. World Influenza Vaccine Production by Application (2024-2029) & (M Units)
Table 57. World Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Influenza Vaccine Product and Services
Table 64. Sanofi Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. CSL Basic Information, Manufacturing Base and Competitors
Table 68. CSL Major Business
Table 69. CSL Influenza Vaccine Product and Services
Table 70. CSL Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. CSL Recent Developments/Updates
Table 72. CSL Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Influenza Vaccine Product and Services
Table 76. GSK Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Viatris Basic Information, Manufacturing Base and Competitors
Table 80. Viatris Major Business
Table 81. Viatris Influenza Vaccine Product and Services
Table 82. Viatris Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Viatris Recent Developments/Updates
Table 84. Viatris Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Influenza Vaccine Product and Services
Table 88. AstraZeneca Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Influenza Vaccine Product and Services
Table 94. Hualan Bio Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 98. Changchun Institute of Biological Major Business
Table 99. Changchun Institute of Biological Influenza Vaccine Product and Services
Table 100. Changchun Institute of Biological Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Changchun Institute of Biological Recent Developments/Updates
Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Major Business
Table 105. Sinovac Influenza Vaccine Product and Services
Table 106. Sinovac Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sinovac Recent Developments/Updates
Table 108. Sinovac Competitive Strengths & Weaknesses
Table 109. BCHT Basic Information, Manufacturing Base and Competitors
Table 110. BCHT Major Business
Table 111. BCHT Influenza Vaccine Product and Services
Table 112. BCHT Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BCHT Recent Developments/Updates
Table 114. BCHT Competitive Strengths & Weaknesses
Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu GDK Major Business
Table 117. Jiangsu GDK Influenza Vaccine Product and Services
Table 118. Jiangsu GDK Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 121. KM Biologics Major Business
Table 122. KM Biologics Influenza Vaccine Product and Services
Table 123. KM Biologics Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Influenza Vaccine Upstream (Raw Materials)
Table 125. Influenza Vaccine Typical Customers
Table 126. Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Influenza Vaccine Picture
Figure 2. World Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Influenza Vaccine Production (2018-2029) & (M Units)
Figure 5. World Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Influenza Vaccine Production (2018-2029) & (M Units)
Figure 9. Europe Influenza Vaccine Production (2018-2029) & (M Units)
Figure 10. China Influenza Vaccine Production (2018-2029) & (M Units)
Figure 11. Japan Influenza Vaccine Production (2018-2029) & (M Units)
Figure 12. Influenza Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 15. World Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 17. China Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 18. Europe Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 19. Japan Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 20. South Korea Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 21. ASEAN Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 22. India Influenza Vaccine Consumption (2018-2029) & (M Units)
Figure 23. Producer Shipments of Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Influenza Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Influenza Vaccine Markets in 2022
Figure 26. United States VS China: Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Influenza Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Influenza Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Influenza Vaccine Production Market Share 2022
Figure 32. World Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Influenza Vaccine Production Value Market Share by Type in 2022
Figure 34. Trivalent Influenza Vaccine
Figure 35. Quadrivalent Influenza Vaccine
Figure 36. World Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Influenza Vaccine Production Value Market Share by Application in 2022
Figure 41. 6 Months to 3 Years
Figure 42. > 3 Years
Figure 43. World Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Influenza Vaccine Industry Chain
Figure 47. Influenza Vaccine Procurement Model
Figure 48. Influenza Vaccine Sales Model
Figure 49. Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs